Arrivo BioVentures
Morrisville, US · Delaware LLC · 1 known investors
Biotech
Founders & leadership
KA
Karen AdamsExecutive Officer
SE
Stephen E. ButtsExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$43.2MraisedNov 2023 · 58 investors · BiotechnologyRule 506(b)
▶$43.2MraisedNov 2023 · 58 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen AdamsExecutive Officer
- Stephen E. ButtsExecutive Officer
- Offering amount
- $45.3M
- Amount sold
- $43.2M
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.